Daishin Balance No.6 Special Purpose Acquisition Co. Ltd
KUKJEON PHARMACEUTICAL Co., Ltd operates as a chemical total solutions provider in South Korea. It provides various chemical-based products and services; and after-sales services, such as research and development, production, quality control, and DMF services. The company manufactures active pharmaceutical ingredients; and offers molecular design and technical support. It develops electronic mate… Read more
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750) - Net Assets
Latest net assets as of September 2025: ₩98.41 Billion KRW
Based on the latest financial reports, Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750) has net assets worth ₩98.41 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩177.78 Billion) and total liabilities (₩79.37 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩98.41 Billion |
| % of Total Assets | 55.35% |
| Annual Growth Rate | 31.86% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 66.14 |
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd - Net Assets Trend (2020–2024)
This chart illustrates how Daishin Balance No.6 Special Purpose Acquisition Co. Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (2020–2024)
The table below shows the annual net assets of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩97.42 Billion | -0.04% |
| 2023-12-31 | ₩97.46 Billion | +5.56% |
| 2022-12-31 | ₩92.32 Billion | +11.03% |
| 2021-12-31 | ₩83.15 Billion | +157.99% |
| 2020-12-31 | ₩32.23 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Daishin Balance No.6 Special Purpose Acquisition Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 157.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩30.37 Billion | 31.18% |
| Common Stock | ₩4.91 Billion | 5.04% |
| Other Components | ₩62.14 Billion | 63.78% |
| Total Equity | ₩97.42 Billion | 100.00% |
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd Competitors by Market Cap
The table below lists competitors of Daishin Balance No.6 Special Purpose Acquisition Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bamboo Capital JSC
VN:BCG
|
$65.87 Million |
|
Sungshin Cemen
KO:004980
|
$65.88 Million |
|
Canadian Net Real Estate Investment Trust
PINK:CNNRF
|
$65.89 Million |
|
Socovesa
SN:SOCOVESA
|
$65.90 Million |
|
Ajmera Realty & Infra India Limited
NSE:AJMERA
|
$65.86 Million |
|
Madhya Bharat Agro Products Limited
NSE:MBAPL
|
$65.85 Million |
|
Compagnie du Cambodge
PA:CBDG
|
$65.84 Million |
|
Americas Car-Mart Inc
NASDAQ:CRMT
|
$65.84 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Daishin Balance No.6 Special Purpose Acquisition Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 96,421,535,430 to 97,419,913,560, a change of 998,378,130 (1.0%).
- Net income of 1,736,210,520 contributed positively to equity growth.
- Dividend payments of 490,691,520 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩1.74 Billion | +1.78% |
| Dividends Paid | ₩490.69 Million | -0.5% |
| Other Changes | ₩-247.14 Million | -0.25% |
| Total Change | ₩- | 1.04% |
Book Value vs Market Value Analysis
This analysis compares Daishin Balance No.6 Special Purpose Acquisition Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.34x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 5.99x to 2.34x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | ₩776.59 | ₩4655.00 | x |
| 2021-12-31 | ₩1694.56 | ₩4655.00 | x |
| 2022-12-31 | ₩1866.70 | ₩4655.00 | x |
| 2023-12-31 | ₩1965.01 | ₩4655.00 | x |
| 2024-12-31 | ₩1985.36 | ₩4655.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Daishin Balance No.6 Special Purpose Acquisition Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.78%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.27%
- • Asset Turnover: 0.64x
- • Equity Multiplier: 2.18x
- Recent ROE (1.78%) is below the historical average (2.22%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -10.29% | -4.11% | 1.39x | 1.79x | ₩-6.54 Billion |
| 2021 | 4.86% | 4.73% | 0.80x | 1.29x | ₩-4.28 Billion |
| 2022 | 9.77% | 8.63% | 0.53x | 2.14x | ₩-211.90 Million |
| 2023 | 5.00% | 3.95% | 0.54x | 2.33x | ₩-4.82 Billion |
| 2024 | 1.78% | 1.27% | 0.64x | 2.18x | ₩-8.01 Billion |
Industry Comparison
This section compares Daishin Balance No.6 Special Purpose Acquisition Co. Ltd's net assets metrics with peer companies in the Drug Manufacturers - General industry.
Industry Context
- Industry: Drug Manufacturers - General
- Average net assets among peers: $138,724,008,377
- Average return on equity (ROE) among peers: 3.90%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Daishin Balance No.6 Special Purpose Acquisition Co. Ltd (307750) | ₩98.41 Billion | -10.29% | 0.81x | $65.86 Million |
| PharmGen Science Inc (004720) | $249.43 Billion | 1.12% | 0.46x | $34.69 Million |
| Korean Drug Co. Ltd (014570) | $65.05 Billion | 5.99% | 0.17x | $14.60 Million |
| BCWORLD PHARM. Co. Ltd (200780) | $101.69 Billion | 4.58% | 0.90x | $19.54 Million |